Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,888 | 189 | 98.6% |
| Education | $41.34 | 5 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPKO Pharmaceuticals, LLC | $421.76 | 34 | $0 (2023) |
| Relypsa, Inc. | $316.87 | 22 | $0 (2020) |
| Amgen Inc. | $258.22 | 15 | $0 (2023) |
| Keryx Biopharmaceuticals, Inc. | $253.07 | 13 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $215.41 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $172.09 | 11 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $101.73 | 7 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $98.81 | 7 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $93.87 | 6 | $0 (2023) |
| Genentech USA, Inc. | $82.45 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $205.79 | 14 | Otsuka America Pharmaceutical, Inc. ($70.20) |
| 2023 | $136.07 | 9 | Mallinckrodt Hospital Products Inc. ($34.71) |
| 2022 | $253.32 | 14 | Aurinia Pharma U.S., Inc. ($45.89) |
| 2021 | $335.14 | 21 | AstraZeneca Pharmaceuticals LP ($66.24) |
| 2020 | $91.40 | 6 | OPKO Pharmaceuticals, LLC ($25.99) |
| 2019 | $640.64 | 50 | Relypsa, Inc. ($161.74) |
| 2018 | $631.92 | 42 | OPKO Pharmaceuticals, LLC ($111.02) |
| 2017 | $634.89 | 38 | Keryx Biopharmaceuticals, Inc. ($189.91) |
All Payment Transactions
194 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Immunology | ||||||
| 11/12/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Nephrology | ||||||
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Immunology | ||||||
| 09/22/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: NEPHROLOGY | ||||||
| 08/29/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.78 | General |
| 08/28/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 08/28/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 08/06/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 07/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: NEPHROLOGY | ||||||
| 03/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEPHROLOGY | ||||||
| 02/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Diabetes | ||||||
| 02/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: NEPHROLOGY | ||||||
| 12/19/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Diabetes | ||||||
| 11/21/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/17/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Hematology | ||||||
| 05/01/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: KRYSTEXXA | ||||||
| 04/20/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Genetic Disease | ||||||
| 03/27/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEPHROLOGY | ||||||
| 03/21/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Inflammation | ||||||
| 10/18/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/20/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 7,012 | 11,807 | $2.9M | $396,494 |
| 2022 | 52 | 8,565 | 20,115 | $1.7M | $478,417 |
| 2021 | 45 | 7,780 | 18,662 | $1.3M | $362,433 |
| 2020 | 45 | 8,877 | 21,621 | $1.7M | $423,287 |
All Medicare Procedures & Services
189 procedure records from CMS Medicare Utilization — Page 3 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83970 | Parathormone (parathyroid hormone) level | Office | 2022 | 469 | 707 | $119,264 | $28,500 | 23.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 61 | 108 | $74,008 | $24,248 | 32.8% |
| 82306 | Vitamin d-3 level | Office | 2022 | 460 | 643 | $77,797 | $18,592 | 23.9% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2022 | 40 | 2,880 | $106,531 | $18,450 | 17.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 66 | 339 | $38,985 | $16,247 | 41.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 74 | 372 | $55,800 | $13,073 | 23.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 85 | 87 | $41,888 | $12,696 | 30.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 63 | 293 | $48,345 | $10,599 | 21.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 87 | 145 | $30,098 | $7,841 | 26.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 471 | 763 | $26,873 | $7,841 | 29.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 637 | 1,018 | $32,342 | $7,727 | 23.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 632 | 964 | $20,389 | $4,864 | 23.9% |
| 82610 | Cystatin c (enzyme inhibitor) level | Office | 2022 | 184 | 232 | $12,890 | $4,170 | 32.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 226 | 226 | $11,512 | $3,896 | 33.8% |
| 84156 | Total protein level, urine | Office | 2022 | 644 | 992 | $14,880 | $3,547 | 23.8% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 154 | 262 | $14,596 | $3,462 | 23.7% |
| 84100 | Phosphate level | Office | 2022 | 451 | 730 | $13,052 | $3,376 | 25.9% |
| 80069 | Kidney function blood test panel | Office | 2022 | 312 | 392 | $11,054 | $3,332 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 22 | $9,019 | $3,002 | 33.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 29 | 52 | $10,915 | $2,904 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 526 | 843 | $7,587 | $2,491 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $10,455 | $2,298 | 22.0% |
| 83550 | Iron binding capacity | Office | 2022 | 155 | 264 | $9,433 | $2,230 | 23.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $7,427 | $2,180 | 29.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 100 | 152 | $9,366 | $2,180 | 23.3% |
About Dr. Brant Holt, MD
Dr. Brant Holt, MD is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437123528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brant Holt, MD has received a total of $2,929 in payments from pharmaceutical and medical device companies, with $205.79 received in 2024. These payments were reported across 194 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,888).
As a Medicare-enrolled provider, Holt has provided services to 32,234 Medicare beneficiaries, totaling 72,205 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 189 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Chattanooga, TN
- Active Since 02/15/2006
- Last Updated 05/28/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1437123528
Products in Payments
- Veltassa (Drug) $385.29
- Rayaldee (Drug) $300.85
- Auryxia (Drug) $253.07
- Parsabiv (Biological) $141.25
- RAYALDEE (Drug) $120.91
- ACTHAR (Biological) $119.29
- SAMSCA (Drug) $118.46
- JYNARQUE (Drug) $96.95
- LUPKYNIS (Drug) $93.87
- Velphoro (Drug) $86.21
- Rituxan (Biological) $82.45
- BENLYSTA (Biological) $82.09
- LOKELMA (Drug) $81.80
- FARXIGA (Drug) $78.56
- Edarbi (Drug) $71.41
- JARDIANCE (Drug) $65.66
- Parsabiv (Drug) $64.85
- KRYSTEXXA (Drug) $60.73
- Uloric (Drug) $55.27
- KRYSTEXXA (Biological) $54.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chattanooga
Rohit Gupta, M.d, M.D
Nephrology — Payments: $10,529
Hans Yehnert, Md, MD
Nephrology — Payments: $5,326
Nilesh Patel, M.d, M.D
Nephrology — Payments: $3,184
John Mccarley, M.d, M.D
Nephrology — Payments: $2,939
Mandeep Grewal, Md, MD
Nephrology — Payments: $2,449
Claude Galphin, Md, MD
Nephrology — Payments: $2,379